Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Spyre Therapeutics, Inc. (AGLE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
25 Aug 2022
Souza Marcio
Director
Aeglea BioTherapeutics, Inc.
(AGLE)
90,000
+100%
90,000
$0.56
$50,472.00
BUY
8 Jun 2022
Hanley Jr. Michael Conick
Chief Commercial Officer, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
36,200
+352%
28,200
$0.71
$20,022.00
BUY
16 Mar 2022
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
550,540
+17%
80,079
$2.34
$187,705.19
BUY
11 Mar 2022
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
473,461
+43%
144,666
$1.94
$280,942.97
BUY
11 Mar 2022
Alspaugh Jonathan
Chief Financial Officer, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
165,372
+82%
75,000
$2.08
$156,000.00
BUY
9 Dec 2021
Shanafelt Armen
Director
Aeglea BioTherapeutics, Inc.
(AGLE)
150,000
+100%
150,000
$3.66
$549,692.40
BUY
9 Dec 2021
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
328,795
+19%
53,634
$3.71
$198,972.11
BUY
9 Dec 2021
Alspaugh Jonathan
Chief Financial Officer, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
90,372
+123%
50,000
$3.72
$186,000.00
BUY
16 Aug 2021
Alspaugh Jonathan
Chief Financial Officer, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
40,372
+100%
40,372
$6.51
$262,659.80
BUY
30 Apr 2020
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
538,469
+44%
165,000
$4.75
$783,750.00
BUY
12 Jun 2019
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
353,643
+9%
31,905
$6.16
$196,453.22
BUY
20 May 2019
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
321,738
+9%
26,592
$6.77
$180,032.47
BUY
15 May 2019
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
295,146
+6%
18,713
$6.75
$126,398.71
BUY
7 Dec 2018
Quinn Anthony G.
President & CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
95,787
+3%
2,994
$7.05
$21,115.22
SELL
27 Sep 2018
Schuchart Aaron
Chief Business Officer, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
8,400
-41%
6,000
$9.50
$57,005.00
SELL
11 May 2018
Novartis Bioventures Ltd
10% Owner
Aeglea BioTherapeutics, Inc.
(AGLE)
2,175,314
-0%
19,550
$10.06
$196,673.02
SELL
9 May 2018
Novartis Bioventures Ltd
10% Owner
Aeglea BioTherapeutics, Inc.
(AGLE)
2,194,864
-3%
73,955
$10.12
$748,139.50
SELL
7 May 2018
Novartis Bioventures Ltd
10% Owner
Aeglea BioTherapeutics, Inc.
(AGLE)
2,268,819
-1%
42,105
$10.06
$423,556.97
BUY
6 Dec 2017
Quinn Anthony G.
Interim CEO, Director, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
35,409
+30%
8,288
$4.96
$41,078.38
BUY
1 Dec 2017
York Charles N II
Chief Financial Officer and VP, Officer
Aeglea BioTherapeutics, Inc.
(AGLE)
34,787
+294%
25,959
$4.48
$116,222.95
BUY
1 Dec 2017
Quinn Anthony G.
Director
Aeglea BioTherapeutics, Inc.
(AGLE)
27,121
+171%
17,121
$4.86
$83,177.50
BUY
16 Feb 2017
ORBIMED ADVISORS LLC
10% Owner
Aeglea BioTherapeutics, Inc.
(AGLE)
1,469,524
+8%
109,300
$5.16
$563,882.00
BUY
12 Apr 2016
Cox Russell J.
Director
Aeglea BioTherapeutics, Inc.
(AGLE)
7,000
+100%
7,000
$10.00
$70,000.00
BUY
12 Apr 2016
Novartis Bioventures Ltd
10% Owner
Aeglea BioTherapeutics, Inc.
(AGLE)
2,310,924
+14%
300,000
$10.00
$3,000,000.00
BUY
12 Apr 2016
LILLY ELI & CO
10% Owner
Aeglea BioTherapeutics, Inc.
(AGLE)
2,568,543
+24%
500,000
$10.00
$5,000,000.00
BUY
12 Apr 2016
Quinn Anthony
Director
Aeglea BioTherapeutics, Inc.
(AGLE)
10,000
+100%
10,000
$10.00
$100,000.00
Home